Hepatocyte mRNA translation machinery

The hepatocyte mRNA translation machinery is the integrated system of ribosomes, eukaryotic initiation factors (eIFs), and regulatory proteins within liver cells that executes protein synthesis. This machinery is a primary target for mRNA-based therapeutics, which utilize the liver's high capacity for protein production to synthesize therapeutic enzymes for treating metabolic disorders like methylmalonic acidemia [1, 3, 5]. In the context of hepatocellular carcinoma, the machinery is often hijacked by oncogenic signaling, leading to the over-translation of proteins that promote tumor growth and survival [2]. Therapeutic strategies include the delivery of exogenous mRNA to be translated by this machinery or the use of small molecules to inhibit specific components like eIF4E or the mTOR pathway [2, 4]. Monitoring the activity of this machinery through biomarkers like phosphorylated ribosomal protein S6 is crucial for assessing therapeutic efficacy and safety [2, 5]. The machinery's central role in liver metabolism makes it a versatile platform for both gene replacement and anti-cancer interventions [1, 5].

Other names

Hepatic translational apparatusLiver protein synthesis machineryHepatocyte ribosome-initiation factor complex

The mechanism involves the recruitment of host ribosomes, eukaryotic initiation factors (eIFs), and tRNAs to translate exogenous mRNA templates into functional proteins, or the targeted inhibition of these components to prevent the synthesis of pathological proteins.